Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Stukalin

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
JAMA Network Open|June 23, 2023
Treatment-Free Survival After Nivolumab vs Pembrolizumab vs Nivolumab-Ipilimumab for Advanced MelanomaMehul Gupta, Igor Stukalin, Daniel Meyers, et al.
CMAJ Open|January 19, 2022
Medications and dosages used in medical assistance in dying: a cross-sectional studyIgor Stukalin, Oluwatobi R Olaiya, Viren Naik, et al.
Neuro-Oncology Practice|September 16, 2024
Healthcare spending versus mortality in central nervous system cancer: Has anything changed?Eddie Guo, Mehul Gupta, Heather Rossong, et al.
Current Medical Research and Opinion|October 16, 2025
Closing the loop in colorectal cancer screening: real-world adherence to follow-up colonoscopy after positive mt-sDNA vs FIT/FOBT, stratified by payer typeMallik Greene, Brad Stieber, Joseph W LeMaster, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
Clinical Factors Associated with Long-Term Survival in Metastatic Melanoma Treated with Anti-PD1 Alone or in Combination with IpilimumabSiddhartha Goutam, Igor Stukalin, Benjamin Ewanchuk, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 27, 2025
"We're the silent people in the situation": a qualitative examination of the lived experiences of young partners of men diagnosed with testicular cancerFiona S M Schulte, Perri Tutelman, Emily Memedovich, et al.
Current Oncology (Toronto, Ont.)|October 27, 2023
Effectiveness of Immune Checkpoint Inhibitor with Anti-PD-1 Monotherapy or in Combination with Ipilimumab in Younger versus Older Adults with Advanced MelanomaTaylor E Woo, Igor Stukalin, Philip Q Ding, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 12, 2024
"Uncovering the unspoken": a narrative analysis of patients' experiences with testicular cancerBarry D Bultz, Brian Kelly, Zeev Rosberger, et al.
Clinical Therapeutics|November 24, 2025
Evaluation of Colorectal Cancer Incidence in the United States From 2021 to 2024 Using a National Multi-Payer Claims DatabaseMallik Greene, Shrey Gohil, Brad Stieber, et al.
The American Journal of Gastroenterology|May 17, 2021
Trends in the Economic Burden of Chronic Liver Diseases and Cirrhosis in the United States: 1996-2016Christopher Ma, Alexander S Qian, Nghia H Nguyen, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
JAMA Network Open|June 23, 2023
Treatment-Free Survival After Nivolumab vs Pembrolizumab vs Nivolumab-Ipilimumab for Advanced MelanomaMehul Gupta, Igor Stukalin, Daniel Meyers, et al.
CMAJ Open|January 19, 2022
Medications and dosages used in medical assistance in dying: a cross-sectional studyIgor Stukalin, Oluwatobi R Olaiya, Viren Naik, et al.
Neuro-Oncology Practice|September 16, 2024
Healthcare spending versus mortality in central nervous system cancer: Has anything changed?Eddie Guo, Mehul Gupta, Heather Rossong, et al.
Current Medical Research and Opinion|October 16, 2025
Closing the loop in colorectal cancer screening: real-world adherence to follow-up colonoscopy after positive mt-sDNA vs FIT/FOBT, stratified by payer typeMallik Greene, Brad Stieber, Joseph W LeMaster, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
Clinical Factors Associated with Long-Term Survival in Metastatic Melanoma Treated with Anti-PD1 Alone or in Combination with IpilimumabSiddhartha Goutam, Igor Stukalin, Benjamin Ewanchuk, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 27, 2025
"We're the silent people in the situation": a qualitative examination of the lived experiences of young partners of men diagnosed with testicular cancerFiona S M Schulte, Perri Tutelman, Emily Memedovich, et al.
Current Oncology (Toronto, Ont.)|October 27, 2023
Effectiveness of Immune Checkpoint Inhibitor with Anti-PD-1 Monotherapy or in Combination with Ipilimumab in Younger versus Older Adults with Advanced MelanomaTaylor E Woo, Igor Stukalin, Philip Q Ding, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 12, 2024
"Uncovering the unspoken": a narrative analysis of patients' experiences with testicular cancerBarry D Bultz, Brian Kelly, Zeev Rosberger, et al.
Clinical Therapeutics|November 24, 2025
Evaluation of Colorectal Cancer Incidence in the United States From 2021 to 2024 Using a National Multi-Payer Claims DatabaseMallik Greene, Shrey Gohil, Brad Stieber, et al.
The American Journal of Gastroenterology|May 17, 2021
Trends in the Economic Burden of Chronic Liver Diseases and Cirrhosis in the United States: 1996-2016Christopher Ma, Alexander S Qian, Nghia H Nguyen, et al.
Pageof 4